World's first medical networking and resource portal

Dr. Abbas Ali's Profile
MANAGEMENT OF ACTIVE PULMONARY TUBERCULOSIS IN GENERAL PRACTICE
MANAEMENT OF ACTIVE PULMONARY TUBERCULOSIS IN GENERAL PRACTICE
DR.S.ABBAS ALI
MD DNB MNAMS
Fellowship in clinical cardiology
PGDHSC (Ultrasonography)
PGDHSc (Echocardiogram)
FCGP., MCCP (cardiology)
230/12 Chandralok colony
NH-2 Goverdhan chauraha
Mathura – 281004
Uttar Pradesh

Pulmonary tuberculosis is a sub acute respiratory infection with acid fast bacilli Mycobacterium tuberculosis. The most frequent symptoms are cough, fever, night sweats and malaise. Cough in pulmonary tuberculosis is initially non-productive, but often progress to sputum production and in some cases Haemoptysis. The sputum is generally yellow and is neither malodorous nor thick. Extremely advanced cases may also present with bloody sputum. Rarely, the bleeding is massive leading to shock, asphyxia and death.
Tuberculosis (TB) is one of the top 10 causes of death worldwide. In 2016, 10.4 million people fell ill with TB, and 1.7 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and middle-income countries. Seven countries account for 64% of the total, with India leading the count, followed by Indonesia, China, Philippines, Pakistan, Nigeria, and South Africa. In 2016, an estimated 1 million children became ill with TB and 250 000 children died of TB (including children with HIV associated TB).

The management of active pulmonary tuberculosis starts with proper classification, such as drug susceptible tuberculosis, Drug resistant tuberculosis and HIV-PTB by advising following investigations
• Sputum smear (AFB) examination: • atlest two samples of sputum should be examined. Early morning sputum specimens tend to have a higher yield than specimens collected at either times and overnight sputum collection have provided even greater sensitivity. Presence of AFB confirms the diagnosis that the patient is suffering from active pulmonary tuberculosis. This investigation does not confirm that this active PTB is whether DSPTB or DRPTB or HIV-PTB
• X-ray chest PA view: this is not a confirmatory investigation unless confirmed by sputum microscopy. X-ray chest will be helpful in knowing the extent of damage of lung.
• CB NAAT or Gene xpert of sputum AFB: this is latest weapon which delivers very fast results within 2 hours. This rule out drug susceptibility PTB from Drug resistance PTB. It also rules out Rifampicin Resistance.
• Card test for HIV: It is essential to rule out HIV-PTB. Many TB patients were being treated without knowledge of the presence or absence of concurrent HIV infection. Detection of HIV antibodies among TB patients is crucial to the holistic management.
• The other tests Interferon gamma release essay (TB Gold, TB spot), ADA, PCR Blood and Mantoux test were not helpful in diagnosis of Active Pulmonary Tuberculosis and should not be prescribed.
Classification
DST TB: it is assumed 85% of pulmonary TB cases were drug susceptible and curable. They include new cases, Retreatment and default cases.
DIAGNOSIS: Diagnosis of Drug susceptible tuberculosis requires clinical history plus three investigations such as
• LED microscopy AFB Sputum smear examination
• X-ray chest PA view
• CB NAAT or Gene xpert sputum of AFB: this test is strongly recommended is retreatment and default cases
Management and treatment:
Two months RHEZ and four months RHE if your area is high risk
Rule and treat other comorbidities such diabetes, COPD, anaemia, immunodeficiency etc.
Monitor the therapy using AFB sputum smear examination and X-ray chest every 2 months
Case cured: previous sputum positive TB becomes sputum negative on two occasions of 2 months gap.
Drug Resistant TB: An estimated prevalence of 3% in new cases and 12-15% in retreatment cases. Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat. WHO estimates that there were 600 000 new cases with resistance to rifampicin – the most effective first-line drug, of which 490 000 had MDR-TB. Drug resistance tuberculosis is divided in to two categories; primary resistance, which is the presence of drug resistance in someone who has never had treatment from tuberculosis and secondary resistance, which is the presence of resistance in a patient who has previously been treated for tuberculosis. Primary resistance results from acquiring an infection that is already drug resistance, while secondary resistance is the result of inappropriate therapy which may be either due to patient attitude towards treatment or empirical prescription of drugs by physicians without following fixed guidelines of WHO or serial DST reports. MDRPTB is defined as resistance to at least rifampicin and isoniazid. The treatment of MDRPTB is extremely difficult, since the drugs used are less effective, more costly and poorly tolerated due to drug related side effects. Failure to control drug resistance tuberculosis has led to outbreak of PRE XDRPTB, XDRPTB and XXDRPTB.
PRE XDR-PTB: defined as resistance to Rifampicin, isoniazid plus resistance to fluoroquinolones or second line injectable (3 drugs).
XDR-PTB: defined as resistance to rifampicin, isoniazid plus resistance fluoroquinolones and at least one second line injectables (capreomycin, amikacin, or kanamycin) (four drugs)
XXDR-PTB: resistance to more than four drugs.
DIAGNOSIS: initial diagnosis of drug resistance PTB requires clinical history (such as previous prescriptions) and 3 investigations such as
• LED microscopy AFB sputum smear examination
• X-ray chest PA view
• CB NAAT (Cartridge Based Nucleic acid amplification test) or Gene Xpert: this is initial test in treatment failures.
For Management we require one more test such
• Serial Liquid cultures: liquid culture gives fast results with in three weeks in comparison of solid cultures. The management and treatment of MDRPTB is complex and if family physician has expertise in managing MDRPTB cases, then manage the cases according to serial DST reports. Management of XDRPTB cases were definitely beyond the reach of family physicians and should be referred to specialized Government sectors where such services available.
HIV-PTB: Tuberculosis is a major opportunistic infection of HIV patients’ worldwide and is a leading killer of HIV-positive people: in 2016, 40% of HIV deaths were due to TB. The management again starts with identification and proper classification of TB such as Drug sensitive and Drug resistance, as drug resistance TB has been responsible for high rates of mortality in HIV infected individuals.
DIAGNSOSIS: investigations required for drug susceptible HIV-PTB
• Sputum for AFB
• X-ray chest PA view
• Gene Xpert of sputum
• Rapid card test for HIV : Out of three cards at least two cards of different companies and confirmed by ELISA
For drug resistance HIV-PTB
• Liquid cultures for AFB sputum
Investigations for Management and follow-up:
• CD4 cell count:
• Viral load
• Haemogram
• Liver profile
• Identification and management of Comorbities eg. Diabetes, malnutrition
The investigations and treatment of HIV-TB is expensive and this services were available to patients at free of cost nearest Government ART centre. Beside ATT it requires lifelong ART (antiretroviral therapy) which should be initiated within 2 weeks of starting ATT.

Category (General Medicine)  |   Views ( 11626 )  |  User Rating
Rate It

APPROACH TO ANAEMIA IN GENERAL PRACTICE
APPROACH TO ANAEMIA IN GENERAL PRACTICE
DR.S.ABBAS ALI
MD DNB MNAMS
Fellowship in cardiology
PGDCC (ultrasonography)
PGDCC(Echocardiogram)
FCGP,MCCP (Cardiology)
Lecturer, department of medicine
KD MEDICAL COLLEGE, MATHURA

Anaemia is usually defined clinically as a reduction of the haemoglobin concentration to less than 13g/dl (males) or less than 12g/dl (females). Haemoglobin constitutes about 1% of total body weight. It is a common problem in general practice.
Degree of Anaemia: Anaemia is often classified as mild degree (9-11 gm %), moderate
(7-9 gms %), severe (4-7 gm %) and very severe (<4gm %). It is also classified according to Haematocrit (PCV) %.
While evaluating of the patient with anemia and making of specific diagnosis requires a clinical assessment and laboratory investigations. The two must be put together for a comprehensive diagnosis.
Clinical assessment requires careful history and physical examination.
A careful evaluation of medical history often gives vital clues to the cause of anemia. The acuity of anemia, association with other symptoms & history of any chronic illness are important. Some important points
History Comments
Age Iron def. rare before 6 months
Neonatal anemia with reticulocytosis suggests blood loss or Hemolysis.
B-thal. sickle cell anemia appear by 4-8 mths. of age

Genetic & family history X-linked: G-6-PD def
Autosomal dominant: Spherocytosis
Autosomal recessive: Sickle cell anemia, Fanconi
Family member with h/o early cholecystectomy/ biliary calculus
Race & Ethnicity

Nutrition Cows milk & iron deficiency
Strict vegetarian: B12 deficiency
Goat’s milk: Folate def.
Pica, Plumbism & iron def.

Drugs G-6-PD def
Immune mediated hemolysis (Penicillin)
Bone marrow suppression
Phenytoin & folate def.

Diarrhea Malabsorption of iron, B12 &E
Inflammatory bowel disease
Milk protein allergy- chronic blood loss
Intestinal resection & B12 def

Infection Giardia- iron def
Intestinal bacterialovergrowth- blind loop & B12
Epstein barr, CMV & Parvo virus- Bone marrow suppression
Malaria, Kalazar, Chronic infection


Nutritional history related to drugs or alcohol intake and family history of anemia should always be assessed. Certain geographic backgrounds and ethnic origins are associated with an increased likelihood of an inherited disorder of the hemoglobin molecule or intermediary metabolism. Glucose-6-phosphate dehydrogenase (G6PD) deficiency and certain hemoglobinopathies are seen more commonly in those of Middle Eastern or African origin, including African Americans who have a high frequency of G6PD deficiency. Other information that may be useful includes exposure to certain toxic agents or drugs and symptoms related to other disorders commonly associated with anemia.
Physical Examination
 General appearance of child & assessment of growth parameters helps decide the acuity or chronicity of anemia & other associated illnesses.
 Look for signs of trauma
 Presence of petecie, bruising & ecchymosis
 Lymphadenopathy, Hepato-spleenomegaly & abdominal mass. Splenomegaly and lymphadenopathy suggest an underlying lymphoproliferative disease,
 Prominent cheek bones, frontal bossing indicates hemolytic anemia
 Associated congenital malformations- Fanconi anemia.
 Tell tale signs of any chronic illness e.g. hypertension, short stature, arthritis, cluubing, cyanosis etc.
 petechiae suggest platelet dysfunction
 blood in the stool
 In the anemic patient, physical examination may demonstrate a forceful heartbeat, strong peripheral pulses, and a systolic "flow" murmur. The skin and mucous membranes may be pale if the hemoglobin is <80–100 g/L (8–10 g/dL). This part of the physical examination should focus on areas where vessels are close to the surface such as the mucous membranes, nail beds, and palmar creases. If the palmar creases are lighter in color than the surrounding skin when the hand is hyperextended, the hemoglobin level is usually <80 g/L
Laboratory Evaluation: Initial Laboratoryy workup of anemia requires

1. Complete blood count (CBC) and it is the single most important investigation in anaemia. It
should include Hb, Hct, WBC, platelet count and RBC indices viz. RBC count, MCV, MCH, and RDW. The components of the CBC also help in the classification of anemia. Microcytosis is reflected by a lower than normal MCV (<80), whereas high values (>100) reflect macrocytosis. The MCH and MCHC reflect defects in hemoglobin synthesis (hypochromia). Automated cell counters describe the red cell volume distribution width (RDW).
2. Peripheral blood smear examination: A careful evaluation of the peripheral blood smear is important, and clinical laboratories often provide a description of both the red and white cells, a white cell differential count, and the platelet count. In patients with severe anemia and abnormalities in red blood cell morphology and/or low reticulocyte counts, a bone marrow aspirate or biopsy can assist in the diagnosis. The peripheral blood smear also provides important information about defects in red cell production. As a complement to the red cell indices, the blood smear also reveals variations in cell size (anisocytosis) and shape (poikilocytosis).
3. Reticulocyte count: An accurate reticulocyte count is key to the initial classification of anemia. Normally, reticulocytes are red cells that have been recently released from the bone marrow. Normally, the reticulocyte count ranges from 1 to 2% and reflects the daily replacement of 0.8–1.0% of the circulating red cell population.

The above triad comprises the primary investigations in anaemia and can be performed
on a single EDTA blood sample.
Secondary investigations are guided by the results of the above tests in a given clinical context, and may include
1. Tests of Iron Supply and Storage: they include serum ferritin, total iron binding capacity, serum iron, serum transferring percentage. This tests reflect the availability of iron for hemoglobin synthesis. The percent transferrin saturation is derived by dividing the serum iron level (x 100) by the TIBC. The normal serum iron ranges from 9 to 27 mol/L (50–150 g/dL), while the normal TIBC is 54–64 mol/L (300–360 g/dL); the normal transferrin saturation ranges from 25 to 50%. A diurnal variation in the serum iron leads to a variation in the percent transferrin saturation. The serum ferritin is used to evaluate total body iron stores. Adult males have serum ferritin levels that average ~100 g/L, corresponding to iron stores of ~1 g. Adult females have lower serum ferritin levels averaging 30 g/L, reflecting lower iron stores (~300 mg). A serum ferritin level of 10–15 g/L represents depletion of body iron stores. However, ferritin is also an acute-phase reactant and, in the presence of acute or chronic inflammation, may rise several-fold above baseline levels. As a rule, a serum ferritin more than 200 g/L means there is at least some iron in tissue stores.
2. vitamin B12, and RBC folate levels
3. Hb electrophoresis and quantitation (Hb A2, Hb F etc)
4. Blood biochemistry for hepatic and renal functions
5. Bone-marrow aspiration
6. Trephine biopsy from bone marrow
7. Imaging studies may include X-ray chest/ skull/ other bones as warranted, ultrasound abdomen, radio-isotope studies
8. Other specialized tests include Coombs test, osmotic fragility, Ham s test, erythropoietin level, immunocytochemistry, cytogenetics etc
CLINICAL APPROACH TO A PATIENT WITH ANAEMIA
Anaemia is not a disease by itself but only a manifestation of disease. Hence, it is imperative to look for the underlying disease responsible for anaemia.
KEY ISSUES to decide in a patient with anaemia are:
1. Is it a TRUE anaemia?
2. Is the anaemia HEREDIATARY or ACQUIRED?
3. Is there any ABNORMAL BLEEDING?
4. Is there exposure to DRUGS, CHEMICALS, or TOXINS?
5. Is there a co-existing SYSTEMIC DISEASE
6. What is the nature of DIET and ETHNICITY.
CLASSIFICATION OF ANAEMIA broadly anaemia is classified in to
Hereditary : the defect often lies within the RBC. It means its Hb or- its enzyme or- its membrane. Reticulocyte count is high in hereditary anemias.
Acquired: here The defect is often extra-corpuscular
Classification Based on RETICULOCYTE INDEX Normal 0.2 – 2.0%
Reticulocyte count Very Low indicates a decreased RBC production in bone-marrow.
RETICULOCYTE COUNT Very High indicates an excessiveproduction of RBCs in bone-marrow anaemia results from either excessive destruction or excessiveloss of RBCs
RETICULOCYTE Normal (0.2- 2.0%) indicates no positive diagnostic
Classification of anaemia based on MCV (RBC Size) : MCV or mean corpuscular volume is an important parameter to classify anemia.
Microcytic (MCV <80 fl or femtolitres): it is due to inadequate Hb synthesis
Causes
1. Iron deficiency anaemia – commonest
2. Thalasmia
3. Lead toxicity
4. Anaemia of chronic disease
5. Sideroblastic anaemia
Macrocytic (MCV >100 fl)
Causes
MEGALOBLASTIC: Altered DNA synthesisleading to large & fluffy nucleus in the early RBCs
1. Usually from vitamin B12, folate deficiency, or some enzymatic involvement. Segmented nutrophils commonly associated with B12 or folate deficiency anaemia
2. Diet and drugs are the commonest culprit.
3. Increased demand may occur in haemolysis and during pregnancy & lactation
NON-MEGALOBLASTIC: DNA in red cells is normal or OK.
Causes:
1. Liver diseases
2. Alcoholism
3. Aplastic anemia
4. Hypothyroidism
Normocytic (MCV 80-100 fl) Most anaemias start as normocytic. In most diseases, it remains normocytic only
Causes
1. Anaemia of blood loss
2. Anaemia of chronic disease ( sometimes low MCV)
3. Bone marrow failure
4. Renal failure
Differential diagnosis of microcytic anaemia
IRON DIFICIENCY ANAEMIA – DIAGN0SIS THROUGH LAB INVESTIGATIONS
Hb% -- ---low
Serum ferritin ------ low
Total iron binding capacity -----very high
Serum iron ------low
MCV -----low
THALASMIA: It is due to defect in globin chain.
Hb%------normal
Serum ferritin ------normal
Total iron binding capacity------- normal
Serum iron --------normal
MCV ------low
Sideroblastic anaemia
Serum iron : increased
Serum ferritin: increased
Total iron binding capacity: normal
MCV----low
Anaemia of chronic disease:
Serum iron : low
Serum ferritin : increased
Total iron binding capacity : decreased
MCV-----low

Management
The treatment of anemia depends on the cause. Deficiency anemia can be effectively treated by therapeutic doses of the deficient mineral or vitamins. In anaemias, a right treatment may bring patient back to life whereas an inappropriate or delayed treatment may take life away

Category (General Medicine)  |   Views ( 8677 )  |  User Rating
Rate It

RESEARCH ARTICLE ON STUDY OF PREVALENCE OF HIV INFECTION AMONG TUBERCULOSIS AND NON TUBERCULOSIS PATIENTS
STUDY OF PREVALENCE OF HIV INFECTION AND IT’S CLINICAL PROFILE AMONG TUBERCULOSIS PATIENTS AND NON-TUBERCULOSIS PATIENTS – CASE CONTROL STUDY
DR.S.ABBAS ALI
MD, DNB,MNAMS
FCGP, FPC (cardiology)
PGDHSc (Ultrasonography)
PGDHSc (Echocardiogram)
M : 9412178773
Email: dr.abbas1968@gmail.com

ABSTRACT
INTRODUCTION: Tuberculosis is a major opportunistic infection in HIV patients’ world wide. Many patients were being treated for tuberculosis without knowledge of the presence or absence of concurrent HIV infection. Relapse rate is high in HIV-TB, which may be due to re-infections rather than true relapse of TB. Detection of HIV status in a TB patient is critical from both patient and public health perspectives and for holistic management of HIV-TBpatients
Objectives: To determine the prevalence of HIV infection and its clinical profile among tuberculosis patients (Cases) and Non-TB patients (Controls)
Methods: A case-control study study was conducted at SKM hospital, Mathura, Uttar Pradesh during the period September 2009 to February 2011. 252 proven Tuberculosis patients as cases and 252 non-tuberculosis patients (having similar clinical features like TB) as controls selected stratified random sampling method
Results: Out of 252 tuberculosis patients 26 were HIV seropositive and none was positive in Non-TB patients. The percentage of prevalence in TB patients was 10.3%. The prevalence in males 13.2% (19/143) and in females, 6.4% (7/252), 12 (46.15%) were married and 14 (53.85%) were singles, 17 (65.38%) patients were Hindus and 9 (34.62%) were Muslims. 14 (53.85%) patients were from rural areas and 12 (46.15%) patients were from urban areas. 96.2% HIV –TB patients has income below 10000/Rs and all most all HIV – TB patients has heterosexual sexual behavior and not used protective measures during unprotected extramarital sex. The most peculiar clinical features of HIV seropositive TB patients of this study were chronic diarrhea (73%) aphthous ulceration (92.3%), pain in abdomen (38.4%) oral candidiasis (26%) lymphadenopathy (39.8%).
Conclusions: HIV seroprevalence was higher among TB patients and calls for routine HIV screening and counseling of TB suspects for holistic management. Despite the synergy between the human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics, the public health responses have largely been separate. Intensive efforts and early diagnosis of HIV infection among tuberculosis patients was crucial for holistic management of HIV-TB patients. With this study screening of HIV antibodies in TB patients adds one more classification, which will be more helpful in predicting prognosis of disease.


Classification
TB: it is assumed all TB cases (pulmonary and extra-pulmonary) were curable. It can be easily diagnosed by AFB sputum and x-ray chest PA View
Resistant TB: it includes MDR-TB and XDR-TB, which can be easily predicted with the help of previous prescriptions. Management of Resistant TB was beyond the reach of family physician and can be referred to higher centre.
HIV-TB: Can be easily diagnosed in TB patients by rapid card tests. Beside ATT it requires services of nearest ART centre.
Knowledge of HIV status in a TB patient is critical from both patient and public health perspectives. In those patients who test seropositive for HIV, better care can be provided in the form of effective combined antitubercular (ATT) therapy and antiretroviral treatment. ATT was alone insufficient for the treatment of HIV seropositive TB and it was observed during this study that curative outcome was more with addition of antiretroviral therapy. If a HIV-positive TB patient on ATT worsens or fails to improve with therapy, the possibility of other co-existing opportunistic infections or immune reconstitution syndrome should be considered. Knowledge of a person's HIV serostatus also provides the opportunity to administer prophylaxis for opportunistic infections and thereby reduces morbidity and mortality. The spouse and relatives of HIV-seropositve patients may also be counseled on HIV infection and its modes of transmission and prognosis, preventing the spread of infection. Spouses may be educated on safe sex practices and may be offered testing themselves.

Category (General Medicine)  |   Views ( 5629 )  |  User Rating
Rate It

cavitation
Cavity: a cavity is gas containing space with in the lung surrounded by a wall greater than 1mm thick (a gas containing space possessing wall 1mm or thinner is a bulla). The wall thickness up to 5mm is benign and between 5 to 15 mm may be benign or malignant and above 15mm is definitely malignant. see example in photo album nazira x-ray

Category (General Medicine)  |   Views ( 8034 )  |  User Rating
Rate It

cavity
Cavity: a cavity is gas containing space with in the lung surrounded by a wall greater than 1mm thick (a gas containing space possessing wall 1mm or thinner is a bulla). The wall thickness up to 5mm is benign and between 5 to 15 mm may be benign or malignant and above 15mm is definitely malignant.

Category (General Medicine)  |   Views ( 7862 )  |  User Rating
Rate It



None
To
Scrap Flag
Scrap